Dr. Martens (LON:DOCS) Stock Price Down 1.2% – Should You Sell?

Posted by George Bondi on Jul 18th, 2026

Dr. Martens plc (LON:DOCS – Get Free Report) shares dropped 1.2% during mid-day trading on Friday . The stock traded as low as GBX 73.90 and last traded at GBX 75.90. Approximately 1,248,485 shares changed hands during trading, a decline of 85% from the average session volume of 8,174,940 shares. The stock had previously closed at GBX 76.80.

Analyst Upgrades and Downgrades

Several analysts have commented on DOCS shares. Berenberg Bank lowered their target price on shares of Dr. Martens from GBX 114 to GBX 110 and set a “buy” rating for the company in a research note on Tuesday, May 19th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a GBX 100 price target on shares of Dr. Martens in a report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of GBX 105.

Check Out Our Latest Analysis on Dr. Martens

Dr. Martens Price Performance

The company has a 50-day moving average of GBX 70.63 and a two-hundred day moving average of GBX 68.91. The company has a debt-to-equity ratio of 108.85, a current ratio of 2.61 and a quick ratio of 1.13. The stock has a market capitalization of £726.45 million, a PE ratio of 31.63, a P/E/G ratio of 6.40 and a beta of 0.24.

Dr. Martens (LON:DOCS – Get Free Report) last posted its quarterly earnings results on Tuesday, May 19th. The company reported GBX 4.20 EPS for the quarter. Dr. Martens had a return on equity of 6.89% and a net margin of 3.11%.The company had revenue of £764.90 million during the quarter. Sell-side analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Activity at Dr. Martens

In related news, insider Ije Nwokori purchased 118,516 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were bought at an average price of GBX 72 per share, with a total value of £85,331.52. Also, insider Giles Wilson purchased 68,313 shares of the firm’s stock in a transaction on Thursday, June 25th. The stock was bought at an average price of GBX 72 per share, for a total transaction of £49,185.36. Insiders purchased 300,199 shares of company stock worth $22,061,408 over the last three months. Corporate insiders own 2.94% of the company’s stock.

Dr. Martens Company Profile

(Get Free Report)

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.